AKT1 and breast carcinoma: ACLY overexpression and activation increase metabolic activity in proliferating cells via activation of Akt signaling in glioblastoma, colorectal cancer, breast cancer, non-small cell lung cancer, and hepatocellular carcinoma etc. [152].